HOP Medical Centre presents you with a wide range of executive health screening services, centrally located at Orchard / Tampines. Click here to see more

Understanding 10 Common Cancers: A Comprehensive Guide to Early Detection

Published on 18 December 2025

Cancer remains one of the leading health concerns globally, with early detection playing a crucial role in treatment success and survival rates. While the word “cancer” often causes fear, understanding different cancer types, their warning signs, and screening options empowers you to take proactive steps toward protecting your health. This comprehensive guide explores 10 of the most common cancers affecting Singaporeans, helping you understand risk factors, symptoms, and the importance of early detection through advanced screening methods like SPOT-MAS 10.

Why Understanding Different Cancer Types Matters

Not all cancers are the same. Instead, each cancer type has unique characteristics, risk factors, symptoms, and treatment approaches. According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths annually. However, many cancers detected at early stages have significantly improved survival rates.

Furthermore, the Singapore Cancer Registry reports that certain cancers are more prevalent in Singapore’s population. Understanding these common cancers helps you recognize warning signs early and seek appropriate screening, potentially catching cancer when treatment is most effective.

The Power of Early Cancer Detection

Early detection dramatically improves cancer treatment outcomes. For example, breast and colorectal cancers detected at early stages have over 90% survival rates. Additionally, treatment costs for early-stage cancer are typically 2-4 times less expensive than late-stage treatment. Moreover, early detection options are less invasive with faster recovery times.

Modern cancer screening technology, such as the SPOT-MAS 10 multi-cancer early detection test, can identify cancer signals before symptoms appear. Specifically, this innovative test analyzes circulating tumor DNA in a simple blood draw to screen for 10 common cancers simultaneously.

1. Lung Cancer: Understanding Two Main Types

Lung cancer is one of the most common and deadliest cancers worldwide. It develops when abnormal cells in the lungs grow uncontrollably, forming tumors that impair lung function. Furthermore, lung cancer has two main types with different characteristics and treatment approaches.

Small Cell Lung Cancer (SCLC)

Small cell lung cancer accounts for approximately 10-15% of lung cancers. This aggressive cancer type grows and spreads rapidly, often metastasizing before diagnosis. Notably, SCLC strongly associates with smoking, with nearly all cases occurring in current or former smokers.

Risk Factors:

  • Cigarette smoking (primary cause)
  • Secondhand smoke exposure
  • Radon gas exposure
  • Occupational exposure to asbestos, arsenic, or chromium
  • Family history of lung cancer

Warning Signs:

  • Persistent cough that worsens over time
  • Coughing up blood or rust-colored sputum
  • Chest pain that worsens with deep breathing or coughing
  • Shortness of breath and wheezing
  • Hoarseness
  • Unexplained weight loss and loss of appetite
  • Fatigue and weakness
  • Recurrent respiratory infections

Non-Small Cell Lung Cancer (NSCLC)

Non-small cell lung cancer represents 85-90% of lung cancers. In contrast to SCLC, NSCLC grows more slowly and includes several subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. While smoking remains the primary risk factor, NSCLC can also develop in non-smokers.

Early Detection Importance: Lung cancer often causes no symptoms in early stages. Therefore, regular screening for high-risk individuals, particularly those with a significant smoking history, enables earlier detection when treatment is most effective. Consequently, the SPOT-MAS 10 test can detect both small cell and non-small cell lung cancer through blood analysis.

2. Breast Cancer: The Most Common Cancer in Women

Breast cancer develops when abnormal cells in breast tissue grow uncontrollably. While breast cancer primarily affects women, men can also develop this cancer, though rarely. Importantly, early detection through regular screening significantly improves treatment outcomes and survival rates.

Understanding Breast Cancer Development

Breast cancer typically begins in the milk ducts or lobules (milk-producing glands). In most cases, breast cancers are carcinomas, meaning they start in cells that line organs and tissues throughout the body. The two most common breast cancers are invasive ductal carcinoma and invasive lobular carcinoma.

Risk Factors:

  • Being female (though men can develop breast cancer)
  • Increasing age (risk rises after age 50)
  • Family history of breast or ovarian cancer
  • Genetic mutations (BRCA1 and BRCA2 genes)
  • Personal history of breast cancer or certain benign breast conditions
  • Dense breast tissue
  • Early menstruation (before age 12) or late menopause (after age 55)
  • Never having children or having first child after age 30
  • Hormone replacement therapy
  • Obesity
  • Alcohol consumption
  • Radiation exposure to chest

Warning Signs:

  • New lump or mass in the breast or underarm
  • Breast swelling or change in shape
  • Skin dimpling or puckering
  • Nipple retraction or changes
  • Redness or flaky skin on breast or nipple
  • Nipple discharge (other than breast milk)
  • Breast pain (though most breast cancers are painless)

Screening Recommendations: Women should perform monthly breast self-examinations and have clinical breast examinations regularly. Additionally, they should undergo mammography according to age-appropriate guidelines. Our executive health screening packages include breast cancer screening options including mammography and breast ultrasound.

3. Colorectal Cancer: Cancer of the Colon or Rectum

Colorectal cancer affects the colon (large intestine) or rectum. This cancer typically develops from polyps—small growths on the colon or rectum lining. While most polyps are benign, some can become cancerous over time. Importantly, colorectal cancer is highly preventable through screening that detects and removes polyps before they become malignant.

How Colorectal Cancer Develops

Colorectal cancer usually begins as benign polyps that gradually become cancerous over many years. Consequently, regular screening allows doctors to find and remove polyps before cancer develops, making colorectal cancer one of the most preventable cancers.

Risk Factors:

  • Age over 50 (risk increases significantly)
  • Family history of colorectal cancer or polyps
  • Personal history of inflammatory bowel disease (Crohn’s disease or ulcerative colitis)
  • Genetic syndromes (Lynch syndrome, familial adenomatous polyposis)
  • Diet high in red and processed meats
  • Low fiber diet
  • Physical inactivity
  • Obesity
  • Smoking
  • Heavy alcohol consumption
  • Type 2 diabetes

Warning Signs:

  • Changes in bowel habits (diarrhea, constipation, or narrowing of stool lasting more than a few days)
  • Feeling that bowel doesn’t empty completely
  • Blood in stool (either bright red or very dark)
  • Persistent abdominal discomfort (cramps, gas, pain)
  • Unexplained weight loss
  • Constant fatigue or weakness
  • Unexplained iron deficiency anemia

Prevention and Early Detection: Colorectal cancer screening saves lives by detecting cancer early or preventing it through polyp removal. Screening methods include colonoscopy, stool tests, and blood tests. Additionally, the SPOT-MAS 10 test provides an alternative screening option through blood analysis that can detect colorectal cancer signals early.

4. Stomach Cancer: Gastric Malignancy

Stomach cancer, also called gastric cancer, develops when abnormal cells grow uncontrollably in the stomach lining. This cancer often develops slowly over many years, frequently beginning as precancerous changes in the stomach lining that may progress to cancer.

Understanding Stomach Cancer Risk

Stomach cancer rates vary significantly worldwide, with higher rates in East Asia including Singapore. Moreover, the cancer is more common in older adults and occurs more frequently in men than women.

Risk Factors:

  • Helicobacter pylori (H. pylori) infection
  • Diet high in smoked, salted, or pickled foods
  • Diet low in fruits and vegetables
  • Eating foods contaminated with aflatoxin fungus
  • Chronic gastritis (stomach inflammation)
  • Pernicious anemia
  • Stomach polyps
  • Family history of stomach cancer
  • Smoking
  • Being overweight or obese
  • Previous stomach surgery
  • Type A blood
  • Epstein-Barr virus infection

Warning Signs:

  • Poor appetite
  • Unintentional weight loss
  • Abdominal pain or vague discomfort in the upper abdomen
  • Feeling full after eating small amounts
  • Heartburn or indigestion
  • Nausea and vomiting
  • Swelling or fluid buildup in the abdomen
  • Blood in stool (making stool appear black)
  • Fatigue or weakness from anemia

Early Detection Challenges: Stomach cancer often causes no symptoms in early stages, making detection difficult. When symptoms do appear, the cancer may already be advanced. However, regular screening for high-risk individuals, including testing for H. pylori infection and treating it if present, can help prevent stomach cancer development.

5. Liver and Biliary Tract Cancer: Hepatobiliary Malignancies

Liver cancer originates in liver cells, while biliary tract cancers affect the bile ducts or gallbladder. These related cancers share similar risk factors and often require specialized detection methods. Furthermore, the liver is also a common site for cancer metastasis from other organs.

Types of Liver Cancer

Hepatocellular Carcinoma (HCC): The most common primary liver cancer, typically developing in people with chronic liver disease or cirrhosis.

Cholangiocarcinoma (Bile Duct Cancer): Cancer affecting the bile ducts inside or outside the liver.

Risk Factors:

  • Chronic Hepatitis B or C infection
  • Cirrhosis (scarring of the liver)
  • Heavy alcohol consumption
  • Non-alcoholic fatty liver disease
  • Obesity and diabetes
  • Exposure to aflatoxins (toxins from certain molds)
  • Inherited metabolic diseases
  • Primary sclerosing cholangitis (bile duct disease)
  • Liver flukes (parasitic infections)

Warning Signs:

  • Weight loss without trying
  • Loss of appetite
  • Feeling very full after small meals
  • Nausea or vomiting
  • Enlarged liver or spleen
  • Pain in the abdomen or near the right shoulder blade
  • Swelling or fluid buildup in the abdomen
  • Itching
  • Yellowing of skin and eyes (jaundice)
  • Fever
  • Abnormal bruising or bleeding

Prevention Through Screening: People at high risk for liver cancer, particularly those with chronic hepatitis or cirrhosis, benefit from regular surveillance through blood tests and imaging. Additionally, vaccination against Hepatitis B prevents infection and reduces liver cancer risk. Our health screening packages include liver function tests and can be combined with SPOT-MAS 10 screening for comprehensive liver cancer detection.

6. Uterine Cancer: Cancer of the Womb

Uterine cancer, also called endometrial cancer when it begins in the uterus lining, is the most common gynecologic cancer in developed countries. This cancer occurs when abnormal cells in the uterus grow uncontrollably, forming a tumor.

Understanding Uterine Cancer Types

Endometrial Cancer: Begins in the endometrium (uterus lining). Notably, this is the most common type, accounting for over 90% of uterine cancers.

Uterine Sarcoma: Begins in muscle or supporting tissues of the uterus. In contrast, this rarer type is more aggressive.

Risk Factors:

  • Age (most common after menopause)
  • Hormone imbalance (excess estrogen without progesterone)
  • Early menstruation or late menopause
  • Never having been pregnant
  • Obesity
  • Diabetes
  • Polycystic ovary syndrome (PCOS)
  • Tamoxifen use for breast cancer treatment
  • Family history of uterine, colorectal, or ovarian cancer
  • Lynch syndrome (hereditary genetic condition)

Warning Signs:

  • Abnormal vaginal bleeding or discharge (most common symptom)
  • Bleeding between periods
  • Bleeding after menopause
  • Difficult or painful urination
  • Pain during intercourse
  • Pain in the pelvic area
  • Unexplained weight loss

Early Detection Advantage: Uterine cancer often causes symptoms in early stages, particularly abnormal bleeding, leading women to seek medical evaluation when cancer is still highly treatable. Consequently, any postmenopausal bleeding or unusual bleeding patterns warrant immediate medical assessment. The SPOT-MAS 10 test provides additional screening capability through blood analysis.

7. Esophageal Cancer: Cancer of the Food Pipe

Esophageal cancer develops in the esophagus—the hollow tube that carries food and liquids from the throat to the stomach. This cancer typically begins in cells lining the inside of the esophagus and can occur anywhere along its length.

Types of Esophageal Cancer

Adenocarcinoma: Begins in gland cells in the lower part of the esophagus near the stomach. Notably, this type is more common in developed countries and often associated with acid reflux.

Squamous Cell Carcinoma: Begins in flat, thin cells lining the esophagus. In contrast, this type is more common in Asia and often associated with smoking and alcohol consumption.

Risk Factors:

  • Chronic acid reflux or gastroesophageal reflux disease (GERD)
  • Barrett’s esophagus (precancerous condition)
  • Smoking
  • Heavy alcohol use
  • Obesity (increases adenocarcinoma risk)
  • Diet low in fruits and vegetables
  • Drinking very hot liquids regularly
  • History of other head and neck cancers
  • Achalasia (rare disease affecting the esophagus)
  • Age (more common over 50)
  • Being male (men develop esophageal cancer more frequently)

Warning Signs:

  • Difficulty swallowing (dysphagia)
  • Chest pain, pressure, or burning
  • Worsening indigestion or heartburn
  • Coughing or hoarseness
  • Unexplained weight loss
  • Vomiting
  • Bone pain (if cancer has spread)

Detection Challenges: Esophageal cancer rarely causes symptoms in early stages. By the time symptoms appear, cancer has often advanced. However, people with chronic GERD or Barrett’s esophagus should undergo regular surveillance endoscopy to detect precancerous changes or early cancer.

8. Ovarian Cancer: Silent Killer of Women

Ovarian cancer develops when abnormal cells in the ovaries or related structures (fallopian tubes or peritoneum) grow uncontrollably. Often called the “silent killer,” ovarian cancer frequently causes vague symptoms that are easily overlooked until the disease has advanced.

Understanding Ovarian Cancer Types

Ovarian cancers are classified by the cell type where they originate:

Epithelial Ovarian Cancer: Begins in the thin layer of tissue covering the ovaries. Specifically, this is the most common type, accounting for about 90% of ovarian cancers.

Germ Cell Ovarian Cancer: Begins in egg cells. In contrast, this rare type more commonly affects younger women.

Stromal Ovarian Cancer: Begins in structural tissue cells holding the ovary together. Additionally, this rare type produces hormones.

Risk Factors:

  • Age (risk increases with age, most common after menopause)
  • Family history of ovarian, breast, or colorectal cancer
  • Genetic mutations (BRCA1, BRCA2, Lynch syndrome)
  • Never having been pregnant
  • Endometriosis
  • Hormone replacement therapy (especially estrogen-only therapy)
  • Obesity
  • Tall height (associated with increased risk)

Warning Signs:

  • Bloating or swelling of the abdomen
  • Pelvic or abdominal pain
  • Difficulty eating or feeling full quickly
  • Urinary symptoms (urgency or frequency)
  • Fatigue
  • Upset stomach or heartburn
  • Back pain
  • Pain during intercourse
  • Constipation
  • Menstrual changes
  • Abdominal swelling with weight loss

Early Detection Importance: Ovarian cancer causes symptoms even in early stages, but these symptoms are often vague and easily attributed to other conditions. According to research, paying attention to symptoms that are new, occur frequently (more than 12 times per month), and represent a change from normal can help identify ovarian cancer earlier. Furthermore, the SPOT-MAS 10 test provides screening capability that can detect ovarian cancer through blood analysis before obvious symptoms develop.

9. Pancreatic Cancer: A Challenging Cancer to Detect

Pancreatic cancer occurs when abnormal cells grow uncontrollably in the pancreas—an organ behind the stomach that produces enzymes for digestion and hormones including insulin. Notably, pancreatic cancer is particularly challenging because it often causes no symptoms until advanced stages and typically grows and spreads rapidly.

Understanding Pancreatic Cancer

The pancreas has two main functions: producing digestive enzymes (exocrine function) and producing hormones (endocrine function). Most pancreatic cancers are exocrine tumors, with adenocarcinoma being the most common type.

Risk Factors:

  • Smoking (most significant modifiable risk factor)
  • Chronic pancreatitis (long-term pancreas inflammation)
  • Diabetes, particularly new-onset diabetes in older adults
  • Family history of pancreatic cancer or certain genetic syndromes
  • Obesity
  • Age (risk increases with age, most common over 65)
  • Race (higher rates in African Americans)
  • Heavy alcohol consumption
  • Chronic exposure to certain chemicals

Warning Signs:

  • Jaundice (yellowing of skin and eyes)
  • Dark urine
  • Light-colored or greasy stools
  • Abdominal pain that radiates to the back
  • Loss of appetite
  • Unintentional weight loss
  • Nausea and vomiting
  • New-onset diabetes or worsening of existing diabetes
  • Blood clots
  • Fatigue

Detection Challenges and Hope: Pancreatic cancer is difficult to detect early because the pancreas sits deep in the abdomen, making tumors hard to feel during physical exams. Furthermore, symptoms often don’t appear until cancer has grown or spread. Additionally, symptoms are often vague and attributed to other conditions. However, advanced screening methods like SPOT-MAS 10 offer hope for earlier detection through blood analysis that can identify pancreatic cancer signals before traditional methods.

Head and neck cancers include cancers that develop in the mouth, throat, larynx (voice box), nose, sinuses, and salivary glands. These cancers share similar risk factors and treatment approaches, though they affect different anatomical sites.

Common Sites for Head and Neck Cancers

Oral Cavity: Includes lips, tongue, gums, floor and roof of mouth, and inside of cheeks.

Pharynx (Throat): Divided into nasopharynx (upper part behind the nose), oropharynx (middle part including soft palate, base of tongue, and tonsils), and hypopharynx (lower part).

Larynx (Voice Box): Located at the entrance to the windpipe.

Paranasal Sinuses and Nasal Cavity: Spaces around and behind the nose.

Salivary Glands: Glands that produce saliva throughout the mouth and throat.

Risk Factors:

  • Tobacco use (cigarettes, cigars, pipes, chewing tobacco)
  • Heavy alcohol consumption (risk increases dramatically when combined with tobacco)
  • Human papillomavirus (HPV) infection (particularly HPV type 16)
  • Epstein-Barr virus (EBV) infection (linked to nasopharyngeal cancer)
  • Sun exposure (lip cancer)
  • Poor oral hygiene
  • Diet low in fruits and vegetables
  • Exposure to certain chemicals or substances
  • Betel quid chewing (common in South and Southeast Asia)

Warning Signs:

  • Lump or sore that doesn’t heal
  • Persistent sore throat
  • Difficulty swallowing
  • Voice changes or hoarseness lasting more than two weeks
  • White or red patch in the mouth
  • Lump or swelling in the neck
  • Unexplained bleeding in the mouth
  • Numbness in the mouth or tongue
  • Persistent nasal congestion or chronic sinus infections
  • Frequent nosebleeds
  • Pain or ringing in the ears

Prevention and Early Detection: Many head and neck cancers can be prevented by avoiding tobacco and limiting alcohol consumption. Additionally, HPV vaccination reduces risk of HPV-related oropharyngeal cancers. Regular dental check-ups help detect oral cancers early. For comprehensive screening, the SPOT-MAS 10 test can detect head and neck cancers through blood analysis.

SPOT-MAS 10: Revolutionary Multi-Cancer Early Detection

Understanding these 10 common cancers highlights the importance of comprehensive screening. Traditional cancer screening typically focuses on one cancer at a time, requiring multiple tests, procedures, and appointments. However, the SPOT-MAS 10 multi-cancer early detection test revolutionizes cancer screening by detecting 10 common cancers from a single blood draw.

How SPOT-MAS 10 Works

SPOT-MAS 10 harnesses advanced genomics and artificial intelligence to detect cancer at its earliest stages by identifying specific biomarkers in the bloodstream. Specifically, the test analyzes circulating tumor DNA (ctDNA)—tiny fragments of DNA that tumors release into the bloodstream—that may indicate cancer presence before symptoms appear.

The Process:

  1. A doctor provides counseling and obtains necessary consent
  2. A simple blood draw is taken during your healthcare visit
  3. The sample is analyzed for ctDNA that may indicate cancer
  4. Test results are available in 12-18 days
  5. If cancer signals are detected, further diagnostic testing confirms presence and location

SPOT-MAS 10 Test Accuracy

The test demonstrates strong clinical accuracy backed by extensive studies:

  • Sensitivity: 78.1% overall (65.2% for early stages, 88.3% for Stage IIIA)
  • Specificity: 99.8% (extremely low false positive rate)
  • Tissue Origin Accuracy: 84.0% when cancer is detected

These metrics reflect the test’s reliability as a screening tool. However, positive results require follow-up diagnostic procedures to confirm cancer presence.

Who Should Consider SPOT-MAS 10?

The test is recommended for adults over age 40, particularly those at higher risk:

  • Heavy smokers (20 pack-year history)
  • Heavy drinkers (15 cans of beer per week for men, 8 for women)
  • Those with hereditary risks (positive tests for genes like BRCA1, BRCA2, TP53)
  • People with liver diseases (Hepatitis B or C)
  • Individuals with family history of the 10 cancers screened

Combining SPOT-MAS 10 with Comprehensive Health Screening

For optimal cancer detection and overall health monitoring, consider combining SPOT-MAS 10 with comprehensive health screening packages. Our executive health screening and express health screening packages can be enhanced with SPOT-MAS 10 testing. Consequently, you receive blood tests, imaging services through our radiology department, and multi-cancer detection in one convenient visit.

Taking Action: Your Path to Early Cancer Detection

Understanding these 10 common cancers empowers you to recognize warning signs, understand your risk factors, and take proactive steps toward early detection. While this knowledge is valuable, remember that many cancers cause no symptoms in early stages when treatment is most effective.

Steps to Protect Yourself

  1. Know Your Risk Factors: Understand which cancers you may be at higher risk for based on family history, lifestyle, and other factors.
  2. Pay Attention to Your Body: Notice persistent symptoms or changes that are new, frequent, or different from your normal baseline.
  3. Get Regular Screening: Follow age-appropriate screening recommendations for common cancers. Additionally, consider advanced screening like SPOT-MAS 10 for comprehensive early detection.
  4. Make Lifestyle Changes: Reduce modifiable risk factors by quitting smoking, limiting alcohol, maintaining healthy weight, eating nutritious diet, and staying physically active.
  5. Consult Healthcare Professionals: Discuss your cancer risk with doctors and determine appropriate screening schedule for your individual situation.

Frequently Asked Questions

Can one test really screen for 10 different cancers?

Yes, SPOT-MAS 10 analyzes circulating tumor DNA in your blood that different cancers release. Furthermore, advanced genomics and AI identify specific biomarkers associated with each of the 10 cancer types from a single blood sample.

How is SPOT-MAS 10 different from traditional cancer screening?

Traditional screening typically focuses on one cancer at a time (like mammography for breast cancer or colonoscopy for colorectal cancer). In contrast, SPOT-MAS 10 screens for 10 cancers simultaneously from one blood draw, potentially detecting cancers before symptoms appear or in body areas not covered by standard screening.

If SPOT-MAS 10 is negative, does that mean I definitely don’t have cancer?

A negative result means no cancer signals were detected in the blood sample at that time. However, no screening test is 100% accurate. Therefore, continue following recommended screening guidelines for specific cancers and consult your doctor about any concerning symptoms regardless of SPOT-MAS results.

What happens if SPOT-MAS 10 detects a cancer signal?

If the test detects ctDNA associated with cancer, your doctor will recommend follow-up diagnostic testing. Specifically, this may include imaging studies, biopsies, or other procedures to confirm cancer presence and determine its exact location and stage. Consequently, early detection through SPOT-MAS 10 allows for timely intervention.

Is SPOT-MAS 10 suitable for everyone?

The test is recommended for adults over 40 and particularly those with risk factors. However, it should not be performed on individuals diagnosed with cancer within 5 years, those with highly suspected signs of cancer, pregnant women, or those with recent bone marrow transplant or blood transfusion. Moreover, a doctor must prescribe the test after counseling.

How often should I get SPOT-MAS 10 testing?

Annual testing is recommended, particularly for individuals with cancer risk factors. However, your doctor will advise on the appropriate screening schedule based on your individual risk profile and health history.

Does SPOT-MAS 10 replace other cancer screenings?

SPOT-MAS 10 complements but does not replace existing recommended cancer screenings like mammography, colonoscopy, or PAP smears. Instead, it provides an additional layer of protection by screening for multiple cancers simultaneously, including some not covered by routine screening.

The Future of Cancer Detection Starts Today

Cancer detection technology continues advancing, offering new hope for earlier diagnosis and better treatment outcomes. Specifically, the SPOT-MAS 10 multi-cancer early detection test represents a significant step forward in cancer screening, providing convenient, comprehensive screening from a simple blood draw.

Understanding the 10 common cancers that affect Singaporeans most frequently—lung, breast, colorectal, stomach, liver-biliary tract, uterine, esophageal, ovarian, pancreatic, and head and neck cancers—empowers you to recognize warning signs and take proactive steps toward protection. Furthermore, combined with regular health screening and healthy lifestyle choices, comprehensive cancer screening offers the best defense against these serious diseases.

Early detection saves lives. Whether through recognizing symptoms early, following recommended screening guidelines, or utilizing advanced multi-cancer detection like SPOT-MAS 10, taking action today protects your health tomorrow.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Cancer detection, diagnosis, and treatment decisions should be made in consultation with qualified healthcare professionals who can assess your individual health status, risk factors, and medical history. Information about screening tests, including SPOT-MAS 10, is subject to change as new data becomes available. Always consult with your healthcare provider for personalized medical guidance.

With over 20 years of trusted medical expertise in Singapore, comprehensive in-house diagnostic services, and convenient locations in Orchard and Tampines, HOP Medical Centre provides quality cancer screening that protects your health. Whether you choose traditional screening packages, advanced SPOT-MAS 10 multi-cancer detection, or comprehensive health assessments combining both approaches, our experienced medical team is committed to your wellbeing through early detection and professional care. Book your cancer screening consultation today and take an important step toward protecting yourself through early cancer detection.

WhatsApp Chat

Send via WhatsApp